WSU cancer therapy shows promise in trials
By Rachel Tompa, Fred Hutch News PULLMAN, Wash. – A recent small clinical trial for patients with a rare, aggressive brain cancer has shown promise. The targeted cancer therapy enlists a modified yeast protein that is the brainchild of Washington State University biologist Margaret Black.